Type 1 diabetes with other specified/multiple/unspecified complications

E4_DM1NASCOMP

No definition available.

Endpoint definition

FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 E10.6, E10.6+M14.2, E10.6+M14.6, E10.7, E10.8
Hospital discharge: ICD-9 2507B|2508B
Cause of death: ICD-10 E10.6, E10.6+M14.2, E10.6+M14.6, E10.7, E10.8
Cause of death: ICD-9 2507B|2508B
KELA reimbursements: KELA codes ANY
KELA reimbursements: ICD-10 E10

3 out of 7 registries used, show all original rules.

6423

diagram downward connector

Check minimum number of events None

6423

diagram downward connector

Include endpoints None

6423

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

6234

diagram downward connector
E4_DM1NASCOMP

Control definitions

Control exclude E4_DIABETES

Extra metadata

Level in the ICD hierarchy 4
First used in FinnGen datafreeze DF3

Summary Statistics

Key figures

All Female Male
Number of individuals 6234 2973 3261
Unadjusted prevalence (%) 1.65 1.41 1.96
Mean age at first event (years) 37.28 35.05 39.31

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.09 6.38 [4.84, 8.41] 1.4e-39 721
15 years 0.02 3.84 [2.92, 5.06] 1.1e-21 340
5 years 0.01 5.51 [4.30, 7.06] 2.4e-41 164
1 year 0.00 11.77 [8.60, 16.11] 1.6e-53 70

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: E4_DM1NASCOMP – Type 1 diabetes with other specified/multiple/unspecified complications
GWS hits: 32

Survival analyses between endpoints

Plot

before Type 1 diabetes with other specified/multiple/unspecified complications
after Type 1 diabetes with other specified/multiple/unspecified complications

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Type 1 diabetes with other specified/multiple/unspecified complications

Endpoint not on priority list, no data to show.